Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SYNGENE INTERNATIONAL Gains 3%; BSE HEALTHCARE Index Up 0.3%
Wed, 10 Jul 16:17

SYNGENE INTERNATIONAL Gains 3%; BSE HEALTHCARE Index Up 0.3%Image source: hudiemm/www.istockphoto.com

SYNGENE INTERNATIONAL share price has zoomed 3% and is presently trading at Rs 746.0.

Meanwhile, the BSE HEALTHCARE index is at 38,574.3 (up 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are Pfizer (up 6.3%) and KIMS (up 3.1%).

HIKAL CHEMIC (down 2.8%) and ASTRAZENECA PHARMA (down 2.5%) are among the top losers today.

Over the last one year, SYNGENE INTERNATIONAL has moved down from Rs 756.6 to Rs 746.0, registering a loss of Rs 10.6 (down 1.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,922.2 to 38,574.3, registering a gain of 48.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 108.1%), Cadila Healthcare (up 104.7%) and Lupin (up 102.2%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,924.8 (down 0.5%).

The top losers among the BSE Sensex today are M&M (down 6.7%) and Tata Steel (down 2.1%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.

In the meantime, NSE Nifty is at 24,312.4 (down 0.5%). M&M and Hindalco are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,344.2 to 79,924.8, registering a gain of 14,580.6 points (up 22.3%).

SYNGENE INTERNATIONAL Financial Update...

SYNGENE INTERNATIONAL net profit grew 5.5% YoY to Rs 1,886 million for the quarter ended March 2024, compared to a profit of Rs 1,787 million a year ago. Net sales declined 7.8% to Rs 9,169 million during the period as against Rs 9,944 million in January-March 2023.

For the year ended March 2024, SYNGENE INTERNATIONAL reported 9.8% increase in net profit to Rs 5,100 million compared to net profit of Rs 4,644 million during FY23. Revenue of the company grew 9.3% to Rs 34,886 million during FY24.

The current Price to earnings ratio of SYNGENE INTERNATIONAL, based on rolling 12 month earnings, stands at 58.9.


Equitymaster requests your view! Post a comment on "SYNGENE INTERNATIONAL Gains 3%; BSE HEALTHCARE Index Up 0.3%". Click here!